SCHEMBL6958357

SCHEMBL6958357

O=[N+]([O-])c1ccc[c]c1C[C@H]1CO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.36
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
TSHR P16473 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 4/20 0.33
GPR35 Q9HC97 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
RECQL P46063 1/20 0.33
MAPT P10636 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HPGD P15428 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8584092 0.90 ALDH1A1 (0.33) HSD17B10TDP1TSHRMEN1KMT2A
SCHEMBL11148086 0.82 SLC6A2 (0.38) ALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL6205052 0.75 TDP1 (0.42) HSD17B10TDP1TSHRMEN1KMT2A
SCHEMBL4872833 0.74 ALDH1A1 (0.53) HSD17B10TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL8818395 0.74 ALDH1A1 (0.53) HSD17B10TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL7932126 0.74 ALDH1A1 (0.33) TDP1TSHRSMN1; SMN2ALDH1A1
SCHEMBL456245 0.74 TDP1 (0.44) HSD17B10TDP1TSHRMEN1KMT2A
SCHEMBL5585097 0.74 TDP1 (0.41) HSD17B10TDP1TSHRMEN1KMT2A
SCHEMBL1173928 0.71 TDP1 (0.41) HSD17B10TDP1TSHRMEN1KMT2A
SCHEMBL831218 0.70 TDP1 (0.37) HSD17B10TDP1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912170-A4 HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS MERCK & CO INC (US) 2003-04-09 EP disclosed
EP-0912170-A1 HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS Merck & Co., Inc. (US) 1999-05-06 EP disclosed
WO-1997040825-A1 HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS MERCK & CO., INC. (US) 1997-11-06 WO disclosed